Natures Sunshine Products Inc (NATR) Stock Price & Analysis
Natures Sunshine Products Inc (NATR) fell 0.58% to USD 20.4 as of July 25, 2026 at 13:46 UTC, according to Nexqual real-time market data.
NATR last closed at USD 20.52; the session ranged USD 20.08–20.67 on volume of 90,366 shares. Market capitalization is $358.73M, with a 52-week range of USD 12.97–28.14 (NCM). Source: Nexqual, July 25, 2026 at 13:46 UTC.
Key Statistics (as of July 25, 2026 at 13:46 UTC)
| Price | USD 20.4 |
|---|---|
| Change | ▼ 0.58% (down) |
| Previous Close | USD 20.52 |
| Open | USD 20.62 |
| Day Range | USD 20.08 – 20.67 |
| 52-Week Range | USD 12.97 – 28.14 |
| Volume | 90,366 shares |
| Market Cap | $358.73M |
| Exchange | NCM |
Technical Analysis (NATR)
Nexqual's technical model rates NATR "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.91 (neutral) |
| vs SMA50 | Below (USD 21.03) |
| MACD | -0.19 (negative) |
Analyst Ratings (NATR)
Wall Street analysts rate NATR "None" based on 2 analysts, with a mean price target of USD 35 (range USD 33–37), per Nexqual as of July 25, 2026 at 13:46 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 35 |
| High Target | USD 37 |
| Low Target | USD 33 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (NATR)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.29 |
| Revenue Estimate | $126.17M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.3 vs est 0.21 ▲ beat |
| 2025-12-31 | USD 0.3 vs est 0.19 ▲ beat |
| 2025-09-30 | USD 0.36 vs est 0.16 ▲ beat |
| 2025-06-30 | USD 0.35 vs est 0.16 ▲ beat |
Source: Nexqual, July 25, 2026 at 13:46 UTC.
Financials & Fundamentals (NATR)
| Total Revenue | $489.79M |
|---|---|
| Revenue Growth (YoY) | +8.50% |
| Gross Margin | +72.71% |
| Operating Margin | +7.77% |
| Profit Margin | +4.06% |
| ROE | +12.39% |
| Debt / Equity | 13.44 |
| Current Ratio | 2.5 |
| Total Cash | $87.58M |
| Total Debt | $22.43M |
| Free Cash Flow | $23.18M |
Source: Nexqual, July 25, 2026 at 13:46 UTC.
Financial Health Score (NATR)
Nexqual rates Natures Sunshine Products Inc's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 13:46 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 73%, operating 8% |
| Balance Sheet | Strong — $88M cash vs $22M debt, net cash position |
| Cash Flow | Mixed — FCF $23M, slim 4.8% margin |
| Efficiency | Mixed — ROE 12%, ROA 6.8% |
Ownership (NATR)
| Insider Ownership | +3.07% |
|---|---|
| Institutional Ownership | +88.57% |
| Shares Outstanding | 17.58M |
| Float | 12.69M |
| Short % of Float | +3.95% |
Source: Nexqual, July 25, 2026 at 13:46 UTC.
Leadership (NATR)
Natures Sunshine Products Inc is led by Kenneth G. Romanzi (age 65), CEO & Director, per Nexqual as of July 25, 2026 at 13:46 UTC.
| CEO & Director | Kenneth G. Romanzi (age 65) |
|---|---|
| Executive VP & President of Asia/Pacific (APAC) | Daniel C. Norman (age 51) |
| Chief Technology Officer | John Hnanicek |
| Global Chief Marketing Officer | Kevin Fuller Gregory (age 54) |
| Vice President of Global Human Resources | Jason Roberts |
Major Backers & Investors (NATR)
Notable institutional backers of Natures Sunshine Products Inc include WYNNEFIELD CAPITAL INC, Prescott Group Capital Management, L.L.C., American Century Companies Inc, according to Nexqual as of July 25, 2026 at 13:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| WYNNEFIELD CAPITAL INC | 14.07% |
| Prescott Group Capital Management, L.L.C. | 10.14% |
| American Century Companies Inc | 6.78% |
| Kennedy Capital Management, LLC | 3.93% |
| Acadian Asset Management. LLC | 3.74% |
| Renaissance Technologies | 3.02% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.94% |
| Vanguard Group | 6.72% |
| Dimensional Fund Advisors | 5.09% |
| Geode Capital | 2.12% |
Source: Nexqual, July 25, 2026 at 13:46 UTC.
From Natures Sunshine Products Inc's Latest SEC 10-K Filing (filed 2026-03-10)
Key Strengths & Strategy (as disclosed to the SEC)
- The FDCA has been amended several times with respect to dietary supplements, including amendments by the Nutrition Labeling and Education Act of 1990 and the Dietary Supplement Health and Education Act of 1994, as amended, and the regulations promulgated thereunder.   FDA regulations relating specifically to foods and dietary supplements for human use are set forth in Title 21 of the Code of Federal Regulations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NAII | Natural Alternatives Internatio | USD 2.4 | ▲ 0.84% |
| NBN | Northeast Bank | USD 129.24 | ▲ 0.49% |
| NKSH | National Bankshares, Inc. | USD 36.64 | ▲ 1.81% |
| NRIM | Northrim BanCorp Inc | USD 27.09 | ▼ 1.67% |
| LCUT | Lifetime Brands, Inc. | USD 8.69 | ▲ 0.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:46 UTC. This page is informational and not investment advice.